MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Clinical trials for MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE explained in plain language.

Never miss a new study

Get alerted when new MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE trials appear

Sign up with your email to follow new studies for MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Experimental pills target devastating Muscle-Wasting disease in children and adults

Disease control Ongoing

This clinical trial is testing whether two oral supplements (deoxythymidine and deoxycytidine) can help people with a rare genetic disorder called TK2 deficiency. TK2 deficiency causes severe muscle weakness, walking difficulties, and fatigue by reducing the body's cellular energ…

Matched conditions: MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Get alerted when new MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE trials appear

Experimental pills target devastating Muscle-Wasting disease in children and adults